Hepatitis viruses and the MAPK pathway: Is this a survival strategy?
- Milena Panteva,
- Hasan Korkaya,
- Shahid Jameel
- International Centre for Genetic Engineering and Biotechnology
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewSustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>The viruses that cause hepatitis comprise of at least five different agents, which share the ability to cause inflammation and necrosis of the liver. The disease spectrum is quite diverse and the outcome of infection by the different hepatitis viruses can be rationalized based on virus-host cell interactions. New insights into the molecular basis of viral hepatitis reveal that three of these agents - the hepatitis B, C and E viruses (HBV, HCV and HEV) modulate the mitogen-activated protein kinase (MAPK) signaling pathway. In this review we briefly describe the structural organization of the MAPK cascade and emphasize its importance as a central pathway in the signaling network. Selected mechanisms through which HBV, HCV and HEV proteins target various steps in the MAPK pathway are discussed and used to propose a pro-survival outcome for the host cell. In addition, we offer an insight into how the common theme of MAPK activation and its downstream effects may be used to rationalize the different outcomes of hepatitis B, C and E.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 131-140 (10 pages)Journal (Volume, Issue Number)
Virus Research (Volume 92, Issue 2)Publication milestones
- Published - 04/01/2003
Publication status
Published - 04/01/2003
ISSN
0168-1702Publication IDs
- Scopus: 0037383040
- PubMed: 12686421
Publication metrics
Metrics
SciVal
FWCI
0.52
SciVal
Author count
3
SciVal
citations
56
SciVal
Paper percentile
87
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Mentions
1
Citation count
81
Captures
45
Funding Details
Work in the authors’ laboratory is supported by internal funds from the ICGEB and through an International Senior Research Fellowship in Biomedical Sciences of the Wellcome Trust. M.P. extends sincere gratitude to Assoc. Prof. T. Varadinova for the encouragement and support during the early stages of her career.
FundersFunding numbers
WT
-ICGEB
-